In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Esperion Therapeutics Inc (NASDAQ: ESPR) closed the day trading at $2.45 down -4.47% from the previous closing price of $2.57. In other words, the price has decreased by -$4.47 from its previous closing price. On the day, 6.59 million shares were traded. ESPR stock price reached its highest trading level at $2.67 during the session, while it also had its lowest trading level at $2.44.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on December 18, 2024, initiated with a Neutral rating and assigned the stock a target price of $4.
On December 17, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $8.
BofA Securities Downgraded its Neutral to Underperform on June 20, 2024, while the target price for the stock was maintained at $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 17 ’25 when Looker Benjamin sold 6,267 shares for $2.80 per share. The transaction valued at 17,573 led to the insider holds 393,670 shares of the business.
Koenig Sheldon L. sold 28,427 shares of ESPR for $79,254 on Sep 17 ’25. The President and CEO now owns 1,518,831 shares after completing the transaction at $2.79 per share. On Sep 17 ’25, another insider, Halladay Benjamin, who serves as the Chief Financial Officer of the company, sold 7,046 shares for $2.81 each. As a result, the insider received 19,785 and left with 474,862 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 568634048 and an Enterprise Value of 1007101056. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.85. Its current Enterprise Value per Revenue stands at 3.756 whereas that against EBITDA is -28.497.
Stock Price History:
The Beta on a monthly basis for ESPR is 0.91, which has changed by 0.24873102 over the last 52 weeks, in comparison to a change of 0.15822446 over the same period for the S&P500. Over the past 52 weeks, ESPR has reached a high of $3.94, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is 4.17%, while the 200-Day Moving Average is calculated to be 47.70%.
Shares Statistics:
Over the past 3-months, ESPR traded about 6.61M shares per day on average, while over the past 10 days, ESPR traded about 10437340 shares per day. A total of 200.16M shares are outstanding, with a floating share count of 196.99M. Insiders hold about 2.30% of the company’s shares, while institutions hold 48.91% stake in the company. Shares short for ESPR as of 1757894400 were 24801814 with a Short Ratio of 3.75, compared to 1755216000 on 22636104. Therefore, it implies a Short% of Shares Outstanding of 24801814 and a Short% of Float of 12.36.
